Article
11 Feb 2026
Pharmaceutical Direct To Consumer Programs: OIG's Low-Risk Roadmap For Drug Discounts & Congressional Concerns On TrumpRx Compliance
AUTHORS CONTENT
Article
05 Feb 2026
Congress Probes Chinese Biotech GLP-1 Product Compliance
Article
05 Feb 2026
FDA Clinical Decision Support Software Guidance Refresh : Clearer Rules, Broader Innovation
Article
03 Feb 2026
From The Locked Medicine Cabinet To Locker Rooms: The Sports Playbook For Medication Compliance; Assessing The Risks And Realities
Article
26 Dec 2025
Beyond Borders 2025: The Top Five Considerations On The Road To Success In Cross-border Life Sciences M&A
Article
20 Nov 2025
Unlocking Bespoke Product Approvals: FDA Puts Forth Plausible Mechanism Pathway
Article
19 Nov 2025
Heading For An M&A? Understand The Risks And Mitigation Strategies For Clinical Trial Agreements
Article
27 Oct 2025
Privacy, Data And Cybersecurity Quick Clicks | Issue 34
Article
10 Oct 2025
FDA Launches New ANDA Prioritization Pilot To Support U.S.-Based Generic Manufacturing
Article
08 Oct 2025
FDA Seeks Stakeholder Feedback On AI-Enabled Medical Device Performance
Article
29 Sep 2025
Privacy, Data And Cybersecurity Quick Clicks | Issue 33
Article
16 Sep 2025
FDA's AI-Powered Crackdown On Alleged Deceptive Drug Promotions
Article
10 Sep 2025
Getting The Green Light: FDA's New Safeguards For GLP-1 Imports
Article
12 Aug 2025
FDA PreCheck: Fast-Lane Approval To Boost U.S. Drug Manufacturing And Supply Chain Security
Article
05 Aug 2025
USDA Ramps Up Food Safety Strategy
Article
05 Aug 2025
FTC Request For Information Regarding Gender Affirming Care
Article
31 Jul 2025
Texas And Louisiana Serve Up New Laws On Food Product Labels And Disclosures
Article
03 Jul 2025
FDA Scrutinizes Clinical Trials Exporting U.S. Genetic Material
Article
01 Jul 2025
FDA Requesting Comments On Proposed Guidance Regarding 510(k) Transfers
Article
19 Jun 2025
FDA Reimagined: Faster, Friendlier, And Focused On Cures